KANDA; Yutaka
Patent Applications and Registrations
Patent applications and USPTO patent grants for KANDA; Yutaka.The latest application filed is for "method of producing antibodies with n-glycoside-linked sugar chains lacking fucosylation".
Company Profile
4.61.63
- KANDA; Yutaka - Machida-shi JP
- Kanda; Yutaka - Tokyo JP
- Kanda; Yutaka - Machida JP
- Kanda; Yutaka - Fujisawa JP
- KANDA; Yutaka - La Jolla CA
- Kanda; Yutaka - Fujisawa-shi JP
- Kanda; Yutaka - Chiyoda-ku JP
- Kanda; Yutaka - Shizuoka JP
- Kanda; Yutaka - Sunto-gun JP
- Kanda; Yutaka - Houston TX
Patent Activity
| Patent | Date |
|---|---|
| Method Of Producing Antibodies With N-glycoside-linked Sugar Chains Lacking Fucosylation App 20200017593 - HANAI; Nobuo ; et al. | 2020-01-16 |
| Antibody Composition-producing Cell App 20190360015 - Kanda; Yutaka ; et al. | 2019-11-28 |
| Method of modulating the activity of functional immune molecules Grant 10,233,247 - Hanai , et al. | 2019-03-19 |
| Antibody composition-producing cell Grant 10,233,475 - Kanda , et al. | 2019-03-19 |
| Method Of Modulating The Activity Of Functional Immune Molecules App 20170240647 - HANAI; Nobuo ; et al. | 2017-08-24 |
| Antibody Composition-producing Cell App 20160348145 - KANDA; Yutaka ; et al. | 2016-12-01 |
| Antibody composition-producing cell Grant 9,409,982 - Kanda , et al. August 9, 2 | 2016-08-09 |
| Roller bearing Grant 9,115,759 - Kanda August 25, 2 | 2015-08-25 |
| Anti-CD27 antibody Grant 9,023,999 - Mori , et al. May 5, 2 | 2015-05-05 |
| Antibody Composition-producing Cell App 20150112046 - KANDA; Yutaka ; et al. | 2015-04-23 |
| Antibody composition-producing cell Grant 8,895,266 - Kanda , et al. November 25, 2 | 2014-11-25 |
| Method Of Modulating The Activity Of Functional Immune Molecules App 20140234300 - HANAI; Nobuo ; et al. | 2014-08-21 |
| METHOD FOR INCREASING DEPOSITION OF COMPLEMENT C3b ON BACTERIAL SURFACE AND PHAGOCYTOSIS BY PHAGOCYTE AND A THERAPEUTIC METHOD AND A THERAPEUTIC AGENT FOR BACTERIAL INFECTIONS App 20140212409 - KRISTIAN; Sascha ; et al. | 2014-07-31 |
| Method of modulating the activity of functional immune molecules Grant 8,679,491 - Hanai , et al. March 25, 2 | 2014-03-25 |
| Roller Bearing App 20130336610 - Kanda; Yutaka | 2013-12-19 |
| Recombinant protein S composition Grant 8,501,914 - Kanda , et al. August 6, 2 | 2013-08-06 |
| Antibody Composition-producing Cell App 20130189736 - KANDA; Yutaka ; et al. | 2013-07-25 |
| Anti-iga1 Antibody App 20130059318 - Kaneko; Etsuji ; et al. | 2013-03-07 |
| Cells with altered fucosylation and producing antibodies therefrom Grant 8,367,407 - Kanda , et al. February 5, 2 | 2013-02-05 |
| Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost Grant 8,361,751 - Kanda , et al. January 29, 2 | 2013-01-29 |
| Antibody composition-producing cell Grant 8,329,443 - Kanda , et al. December 11, 2 | 2012-12-11 |
| Glycoengineered, recombinant antibody Grant 8,158,760 - Kanda , et al. April 17, 2 | 2012-04-17 |
| Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody Grant 8,110,195 - Kanda , et al. February 7, 2 | 2012-02-07 |
| Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation Grant 8,101,185 - Kanda , et al. January 24, 2 | 2012-01-24 |
| Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase Grant 8,067,232 - Kanda , et al. November 29, 2 | 2011-11-29 |
| Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation Grant 8,039,595 - Kanda , et al. October 18, 2 | 2011-10-18 |
| Antibody Composition-producing Cell App 20110250643 - KANDA; Yutaka ; et al. | 2011-10-13 |
| Indazole derivatives Grant 7,919,517 - Ohta , et al. April 5, 2 | 2011-04-05 |
| Antibody Composition Exhibiting Cellular Cytotoxicty Due To Glycosylation App 20110059115 - KANDA; YUTAKA ; et al. | 2011-03-10 |
| Antibody Composition Exhibiting Cellular Cytotoxicty Due To Glycosylation App 20110052610 - Kanda; Yutaka ; et al. | 2011-03-03 |
| Antibody Composition Exhibiting Cellular Cytotoxicty Due To Glycosylation App 20110027271 - KANDA; Yutaka ; et al. | 2011-02-03 |
| Antibody composition-producing cell in which enzyme expression is inhibited by RNAi Grant 7,846,725 - Kanda , et al. December 7, 2 | 2010-12-07 |
| Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost App 20100291628 - KANDA; Yutaka ; et al. | 2010-11-18 |
| Hsp90 family protein inhibitors Grant 7,781,485 - Kitamura , et al. August 24, 2 | 2010-08-24 |
| Benzenoid ansamycin derivative Grant 7,776,849 - Yamaguchi , et al. August 17, 2 | 2010-08-17 |
| Method Of Modulating The Activity Of Functional Immune Molecules App 20100196371 - HANAI; NOBUO ; et al. | 2010-08-05 |
| Hsp90 family protein inhibitors Grant 7,767,693 - Nara , et al. August 3, 2 | 2010-08-03 |
| Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor Grant 7,763,246 - Hanai , et al. July 27, 2 | 2010-07-27 |
| Anti-cd27 Antibody App 20100173324 - MORI; Katsuhiro ; et al. | 2010-07-08 |
| Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost Grant 7,749,753 - Kanda , et al. July 6, 2 | 2010-07-06 |
| Recombinant Protein S Composition App 20100162418 - KANDA; Yutaka ; et al. | 2010-06-24 |
| Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation Grant 7,741,442 - Kanda , et al. June 22, 2 | 2010-06-22 |
| Antibody composition-producing cell Grant 7,737,325 - Kanda , et al. June 15, 2 | 2010-06-15 |
| Antibody Composition-Producing Cell App 20100143388 - KANDA; YUTAKA ; et al. | 2010-06-10 |
| Method of modulating the activity of functional immune molecules to interleukin-5 receptor protein Grant 7,718,175 - Hanai , et al. May 18, 2 | 2010-05-18 |
| Method of modulating the activity of functional immune molecules Grant 7,708,997 - Hanai , et al. May 4, 2 | 2010-05-04 |
| Methods for producing antibody compositions with increased ADCC Grant 7,708,992 - Hanai , et al. May 4, 2 | 2010-05-04 |
| Method of producing recombinant antithrombin III composition Grant 7,691,810 - Yamada , et al. April 6, 2 | 2010-04-06 |
| Method of modulating the activity of functional immune molecules to Her-2 Grant 7,687,061 - Hanai , et al. March 30, 2 | 2010-03-30 |
| Method of modulating the activity of functional immune molecules Grant 7,682,610 - Hanai , et al. March 23, 2 | 2010-03-23 |
| Method of modulating the activity of functional immune molecules to CXCR4 protein Grant 7,682,611 - Hanai , et al. March 23, 2 | 2010-03-23 |
| Method of modulating the activity of functional immune molecules to GM2 Grant 7,655,228 - Hanai , et al. February 2, 2 | 2010-02-02 |
| Method of modulating the activity of functional immune molecules to CD52 Grant 7,651,688 - Hanai , et al. January 26, 2 | 2010-01-26 |
| IGF-1R inhibitor Grant 7,605,272 - Kanda , et al. October 20, 2 | 2009-10-20 |
| Hsp90 FAMILY PROTEIN INHIBITORS App 20090247522 - Nara; Shinji ; et al. | 2009-10-01 |
| Antibody Composition-Producing Cell App 20090228994 - KANDA; Yutaka ; et al. | 2009-09-10 |
| Glycoengineered, Recombinant Antibody App 20090191199 - KANDA; Yutaka ; et al. | 2009-07-30 |
| Glycoengineered, Recombinant Antibody App 20090191592 - KANDA; Yutaka ; et al. | 2009-07-30 |
| Hsp90 family protein inhibitors Grant 7,538,224 - Nara , et al. May 26, 2 | 2009-05-26 |
| Hsp90 family protein inhibitors Grant 7,538,241 - Kitamura , et al. May 26, 2 | 2009-05-26 |
| Indazole Derivatives App 20090082348 - Ohta; Yoshihisa ; et al. | 2009-03-26 |
| Igf-1r Inhibitor App 20090054508 - Kanda; Yutaka ; et al. | 2009-02-26 |
| Benzenoid Ansamycin Derivative App 20090048253 - Yamaguchi; Shinpei ; et al. | 2009-02-19 |
| Antitumor Agent App 20090042883 - Kanda; Yutaka ; et al. | 2009-02-12 |
| Indazole derivatives Grant 7,470,717 - Ohta , et al. December 30, 2 | 2008-12-30 |
| Antibody Composition-Producing Cell App 20080261301 - Kanda; Yutaka ; et al. | 2008-10-23 |
| Antibody Composition-Producing Cell App 20080227196 - Kanda; Yutaka ; et al. | 2008-09-18 |
| Antibody composition-producing cell Grant 7,425,446 - Kanda , et al. September 16, 2 | 2008-09-16 |
| Method of Modulating the Activity of Functional Immune Molecules App 20080177043 - Hanai; Nobuo ; et al. | 2008-07-24 |
| Mammalian host cell modified by RNAi to inhibit .alpha. 1,6-fucosyltransferase Grant 7,393,683 - Kanda , et al. July 1, 2 | 2008-07-01 |
| Hsp90 Family protein Inhibitors App 20070265268 - Kitamura; Yushi ; et al. | 2007-11-15 |
| Method of Modulating the Activity of Functional Immune Molecules App 20070207151 - Hanai; Nobuo ; et al. | 2007-09-06 |
| Method of Modulating the Activity of Functional Immune Molecules App 20070166304 - Hanai; Nobuo ; et al. | 2007-07-19 |
| Method of Modulating the Activity of Functional Immune Molecules App 20070166302 - Hanai; Nobuo ; et al. | 2007-07-19 |
| Method of Modulating the Activity of Functional Immune Molecules App 20070166300 - Hanai; Nobuo ; et al. | 2007-07-19 |
| Method of Modulating the Activity of Functional Immune Molecules App 20070166305 - Hanai; Nobuo ; et al. | 2007-07-19 |
| Method of Modulating the Activity of Functional Immune Molecules App 20070166303 - Hanai; Nobuo ; et al. | 2007-07-19 |
| Method of Modulating the Activity of Functional Immune Molecules App 20070166301 - Hanai; Nobuo ; et al. | 2007-07-19 |
| Hsp90 family protein inhibitors App 20070155813 - Kitamura; Yushi ; et al. | 2007-07-05 |
| Indazole derivatives App 20070117856 - Ohta; Yoshihisa ; et al. | 2007-05-24 |
| Method of modulating the activity of functional immune molecules Grant 7,214,775 - Hanai , et al. May 8, 2 | 2007-05-08 |
| Hsp90 family protein inhibitors App 20070032532 - Nara; Shinji ; et al. | 2007-02-08 |
| Antibody Composition-Producing Cell App 20070010009 - Kanda; Yutaka ; et al. | 2007-01-11 |
| Remedy for diseases associated with immunoglobulin gene translocation App 20070004674 - Shiotsu; Yukimasa ; et al. | 2007-01-04 |
| Protein kinase inhibitors App 20060281789 - Shiotsu; Yukimasa ; et al. | 2006-12-14 |
| Antibody composition-producing cell App 20060078990 - Kanda; Yutaka ; et al. | 2006-04-13 |
| Antibody composition-producing cell App 20060078991 - Kanda; Yutaka ; et al. | 2006-04-13 |
| Antibody composition-producing cell App 20060063254 - Kanda; Yutaka ; et al. | 2006-03-23 |
| Antibody composition-producing cell App 20060064781 - Kanda; Yutaka ; et al. | 2006-03-23 |
| Method of producing recombinant antithrombin III composition App 20060024793 - Yamada; Tsuyoshi ; et al. | 2006-02-02 |
| Method of modulating the activity of functional immune molecules App 20060024800 - Hanai; Nobuo ; et al. | 2006-02-02 |
| Method of modulating the activity of functional immune molecules App 20050276805 - Hanai, Nobuo ; et al. | 2005-12-15 |
| Method of modulating the activity of functional immune molecules App 20050272916 - Hanai, Nobuo ; et al. | 2005-12-08 |
| Antibody composition-producing cell App 20050262593 - Kanda, Yutaka ; et al. | 2005-11-24 |
| Cells producing antibody compositions with increased antibody dependent cytotoxic activity Grant 6,946,292 - Kanda , et al. September 20, 2 | 2005-09-20 |
| Sh3 domain binding inhibitors App 20050069999 - Sharma, Sreenath V ; et al. | 2005-03-31 |
| UCS1025 derivatives Grant 6,869,971 - Akama , et al. March 22, 2 | 2005-03-22 |
| Piperidine derivatives Grant 6,861,530 - Nara , et al. March 1, 2 | 2005-03-01 |
| LK6-A derivatives Grant 6,815,449 - Akama , et al. November 9, 2 | 2004-11-09 |
| Production process for antibody composition App 20040132140 - Satoh, Mitsuo ; et al. | 2004-07-08 |
| Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost App 20040110282 - Kanda, Yutaka ; et al. | 2004-06-10 |
| Process for producing avermectin derivative App 20040101936 - Endo, Hirofumi ; et al. | 2004-05-27 |
| LK6-A derivatives App 20030181722 - Akama, Tsutomu ; et al. | 2003-09-25 |
| Pyrrolo [4,3,2-de] quinoline derivatives Grant 6,613,774 - Akama , et al. September 2, 2 | 2003-09-02 |
| Antibody composition-producing cell App 20030115614 - Kanda, Yutaka ; et al. | 2003-06-19 |
| Telomerase inhibitors and methods of their use Grant 6,518,268 - Chin , et al. February 11, 2 | 2003-02-11 |
| Piperidine derivatives App 20020137770 - Nara, Shinji ; et al. | 2002-09-26 |
| Agent for inducing apoptosis App 20020022598 - Hara, Mitsunobu ; et al. | 2002-02-21 |
| Farnesyltransferase inhibitor Grant 5,925,641 - Kanda , et al. July 20, 1 | 1999-07-20 |
| DC 107 derivatives and treatment methods Grant 5,733,924 - Kanda , et al. March 31, 1 | 1998-03-31 |
| Farnesyltransferase inhibitor Grant 5,728,830 - Kanda , et al. March 17, 1 | 1998-03-17 |
| Pyrroloindole derivatives Grant 5,187,186 - Kanda , et al. February 16, 1 | 1993-02-16 |
| DC-88A derivatives useful as antitumor agents Grant 5,117,006 - Saito , et al. May 26, 1 | 1992-05-26 |
| DC-88A derivatives Grant 5,084,468 - Saito , et al. January 28, 1 | 1992-01-28 |
| Pyrroloindole derivatives related to DC-88A compound Grant 5,070,092 - Kanda , et al. December 3, 1 | 1991-12-03 |
| DC-88A derivatives Grant 5,008,271 - Kanda , et al. April 16, 1 | 1991-04-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 